
Pharmaceutical intermediates
Ofloxacin Intermediates
1 pharmaceutical intermediate for Ofloxacin. Indication: Corneal ulcer; Conjunctivitis; Bacterial infection.
About Ofloxacin
- Originator
- Daiichi Sankyo Co., Ltd
- Indication
- Corneal ulcer; Conjunctivitis; Bacterial infection
- Approved Date
- 09/26/1997
Available intermediates
1 intermediate currently listed for Ofloxacin. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| Oxygen-fluorine acid | 82419-35-0 | / | / |
Other programs under O
Building toward Ofloxacin?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →